Measles immunity in different population groups

Author:

Belopolskaya M. A.1,Grigoryeva T. D.2,Avrutin V. Yu.3,Potanina D. V.2,Dmitriev A. V.4,Yakovlev A. A.5

Affiliation:

1. Clinical Infectious Diseases Hospital named after S.P. Botkin; Institute of Experimental Medicine

2. Clinical Infectious Diseases Hospital named after S.P. Botkin

3. Institute for Systems Theory

4. Institute of Experimental Medicine

5. Clinical Infectious Diseases Hospital named after S.P. Botkin; Saint-Petersburg State University

Abstract

Objective: to examine the state of the immunity to measles in different age groups.Materials and methods: In 2018, 4444 people were examined at the Diagnostic Center (virological). Among them, 3783 people were examined using the passive haemagglutination test for measles (manufactured by Pasteur Research Institute of Epidemiology and Microbiology, Russia). In the remaining 661 cases, the IgG to measles were detected using the enzyme-linked immunosorbent assay (ELISA) by VektoMeaseles IgG test (manufactured by Vector-Best, Russia). The correlation between the measles IgG level (ELISA) and the age was examined in 518 patients. Results: In this study, the immunity to measles was shown to be insufficient in all groups of observed people. Even among medical staff, nearly 10% had no protective level of measles antibodies. We have shown that the correlation between the measles IgG level and the age is statistically significant, so that the number of seronegative persons in different age groups differs significantly. Conclusion: The highest ratio of seronegative individuals was found in the age group between 18 and 25 years (52,33%), which can lead to serious measles outbreaks. Hence, this study confirms a strong need for additional immunization in all groups and especially in young population.

Publisher

SPRIDA

Subject

Infectious Diseases

Reference7 articles.

1. Moss WJ. Measles. Lancet. 2017 2;390(10111):2490-2502

2. Melegaro A. Measles vaccination: no time to rest //The Lancet Global Health. – 2019. – 7(3). – P. e282-e283.

3. World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2016 global summary. URL: http:// apps.who. int/immunization_monitoring/globalsummary/cou ntries?countrycriteria%5Bcountry%5D%5B%5D=GIN&commit =OK (18.05.2018)

4. WHO. Measles in Europe: record number of both sick and immunized. Available from: http://www.euro.who.int/en/ media-centre/sections/press-releases/2019/measles-in-europerecord-number-of-both-sick-and-immunized [cited 2019 Feb 21]

5. Pozdnyakov A. A., Chernyavskaya O. P. Manifestations of the Epidemic Process of Measles and Rubella at the Present Stage. Epidemiology and Vaccinal Prevention. 2018; 17 (5): 45–53 (in Russian) DOI: 10.31631/2073-3046-2018-17-5-45-53

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Measles immunity in medical workers in Kazan;Epidemiology and Infectious Diseases;2022-07-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3